▁One 6.1796875
▁of 0.66162109375
▁the 0.28857421875
▁major 4.30078125
▁limitations 6.49609375
▁is 5.40234375
▁the 0.96142578125
▁ins 6.515625
u 0.286865234375
fficient 0.04412841796875
ly 4.53125
▁high 2.828125
▁response 6.5
▁rate 0.8408203125
, 2.30078125
▁ 4.8515625
5 1.9462890625
7 2.501953125
% 1.48828125
▁instead 7.49609375
▁of 0.00592803955078125
▁ 0.73828125
7 1.3046875
0 0.72021484375
% 0.958984375
▁( 2.134765625
Fe 8.203125
ing 3.533203125
old 0.5107421875
▁et 0.8818359375
▁al 0.00962066650390625
., 0.54052734375
▁ 0.04205322265625
2 0.436279296875
0 0.0013294219970703125
1 0.734375
7 2.541015625
). 0.37744140625
▁It 4.0546875
▁can 3.38671875
▁be 0.27099609375
▁fairly 8.328125
▁explained 4.10546875
▁by 0.342041015625
▁the 0.39990234375
▁weak 7.3515625
▁focus 6.4375
▁of 1.0185546875
▁respond 4.33984375
ents 0.07843017578125
▁who 4.2265625
▁have 3.005859375
▁overcome 9.71875
▁severe 5.6015625
▁pain 4.44921875
▁sens 6.88671875
ations 0.7607421875
▁and 1.8251953125
▁de 6.51953125
press 1.66015625
ive 0.10626220703125
▁episodes 2.85546875
. 1.0283203125
▁It 3.294921875
▁is 0.75830078125
▁not 2.806640625
▁clear 2.896484375
▁how 1.9794921875
▁to 2.3984375
▁use 4.30078125
▁these 2.751953125
▁statistics 6.32421875
, 2.662109375
▁as 1.7978515625
▁they 2.251953125
▁still 5.9609375
▁may 4.375
▁be 0.859375
▁relevant 3.537109375
▁for 1.12890625
▁the 1.2900390625
▁overall 4.59375
▁analysis 3.576171875
. 0.72509765625
<0x0A> 0.76416015625
The 1.4072265625
▁analysis 4.5703125
▁of 0.6552734375
▁any 8.140625
▁human 7.75
▁reaction 5.5859375
▁has 4.31640625
▁a 2.06640625
▁high 3.296875
▁potential 2.775390625
▁of 1.541015625
▁subject 2.625
iveness 3.53515625
▁and 1.859375
▁bias 2.08984375
, 1.7705078125
▁especially 2.3515625
▁regarding 4.80859375
▁people 5.59375
▁in 4.12890625
▁severe 2.552734375
▁pain 0.88818359375
▁and 1.84765625
▁un 6.4296875
stable 1.0234375
▁emot 1.7919921875
ional 0.07159423828125
▁condition 3.017578125
. 0.19580078125
▁Perhaps 7.6015625
▁some 5.46875
▁patients 4.30078125
▁tend 4.9921875
▁to 0.018341064453125
▁ex 2.62109375
agger 0.01302337646484375
ate 0.0020694732666015625
▁their 1.083984375
▁de 4.76953125
press 0.6162109375
ive 0.04620361328125
▁state 2.0390625
▁or 2.4296875
▁vice 5.265625
▁vers 0.03173828125
a 5.3882598876953125e-05
, 1.1015625
▁de 6.74609375
- 3.115234375
emph 0.266357421875
as 0.006320953369140625
ize 0.1405029296875
▁serious 6.41015625
▁difficulties 5.18359375
. 0.9970703125
▁Because 6.77734375
▁the 2.658203125
▁survey 2.751953125
▁responses 6.28125
▁were 1.5595703125
▁thoroughly 9.1953125
▁anonymous 3.166015625
, 0.2088623046875
▁the 1.583984375
▁research 1.7744140625
ers 0.169189453125
▁were 2.55078125
▁unable 1.94140625
▁to 0.0022449493408203125
▁carefully 8.0234375
▁analyze 2.42578125
▁each 2.9296875
▁patient 2.875
’ 0.8232421875
s 0.0011882781982421875
▁reaction 3.609375
▁and 1.4501953125
▁compare 3.869140625
▁it 0.68017578125
▁to 0.6650390625
▁the 0.99609375
▁actual 3.708984375
▁states 8.078125
▁of 0.98046875
▁condition 6.96875
. 0.453125
▁More 6.65625
▁accurate 3.61328125
▁answers 4.7734375
▁could 1.828125
▁be 0.5625
▁obtained 1.1435546875
▁by 1.5146484375
▁professional 5.3203125
▁psych 0.98486328125
olog 0.27294921875
ists 0.0023746490478515625
▁via 7.29296875
▁personal 2.771484375
▁communication 4.01953125
▁and 2.455078125
▁behavior 6.35546875
al 0.344482421875
▁analysis 1.69140625
. 0.388427734375
▁However 3.3671875
, 0.0037670135498046875
▁this 1.78125
▁method 2.427734375
▁of 2.869140625
▁research 1.75390625
▁is 1.23046875
▁way 5.73046875
▁more 0.84619140625
▁resource 4.046875
- 0.364013671875
int 1.28515625
ensive 0.0120391845703125
▁and 0.52685546875
▁energy 10.421875
- 0.15625
consum 0.40576171875
ing 0.0036449432373046875
. 0.87890625
<0x0A> 0.448486328125
There 3.69921875
▁is 1.0966796875
▁currently 7.34765625
▁a 1.8193359375
▁severe 4.85546875
▁lack 0.7822265625
▁of 0.0102996826171875
▁information 3.009765625
▁about 1.1796875
▁the 0.70849609375
▁effects 4.01171875
▁of 0.09423828125
▁op 3.607421875
i 3.55859375
ates 0.0230712890625
. 3.732421875
▁They 4.58203125
▁manage 8.7265625
▁pain 3.943359375
▁successfully 5.34765625
, 0.642578125
▁but 0.335693359375
▁the 2.0859375
▁past 9.4765625
▁few 2.55859375
▁dec 1.2529296875
ades 0.0006961822509765625
▁indicated 6.90625
▁the 1.884765625
▁growing 3.291015625
▁concern 3.294921875
▁regarding 2.259765625
▁op 2.20703125
iate 0.55224609375
▁ab 1.400390625
use 0.0173187255859375
▁in 3.80078125
▁forms 8.6484375
▁of 0.11346435546875
▁over 2.998046875
d 0.0806884765625
ose 0.355712890625
▁and 0.60107421875
▁add 0.5693359375
iction 0.01800537109375
. 0.1845703125
▁A 4.17578125
▁more 3.576171875
▁manage 10.375
able 0.0009026527404785156
▁and 2.015625
▁sa 3.45703125
fer 0.00020825862884521484
▁alternative 1.7822265625
▁might 4.56640625
▁be 0.2340087890625
▁medical 5.69921875
▁mar 0.63818359375
iju 0.000980377197265625
ana 3.5762786865234375e-05
. 1.091796875
▁However 2.91796875
, 0.00274658203125
▁the 1.603515625
▁legal 4.17578125
▁status 1.12109375
▁and 3.009765625
▁novel 10.1875
ty 0.10650634765625
▁of 0.1746826171875
▁this 1.30078125
▁drug 1.7177734375
▁do 3.9375
▁not 0.0118255615234375
▁allow 0.5185546875
▁finding 6.93359375
▁a 2.337890625
▁large 2.732421875
▁number 1.041015625
▁of 0.0027446746826171875
▁studies 1.998046875
▁on 2.0703125
▁its 0.734375
▁effect 1.9482421875
iveness 0.1395263671875
. 0.740234375
▁Specifically 8.921875
, 0.1141357421875
▁it 2.4609375
▁concerns 5.1015625
▁the 0.89208984375
▁emot 6.5546875
ional 0.01322174072265625
▁condition 3.8984375
▁of 0.611328125
▁patients 0.625
▁experien 5.98046875
cing 5.841255187988281e-06
▁chron 1.365234375
ic 0.0009489059448242188
▁pain 0.09375
. 0.52392578125
▁This 3.37109375
▁research 2.013671875
▁paper 3.5078125
▁a 2.876953125
ims 0.004058837890625
▁to 0.1273193359375
▁analyze 2.544921875
▁levels 10.6328125
▁of 0.0498046875
▁de 0.5283203125
pression 0.11968994140625
▁and 0.49169921875
▁anx 0.73388671875
iety 0.0007710456848144531
▁among 1.443359375
▁people 1.9814453125
▁receiving 4.52734375
▁ther 5.1796875
apy 0.049774169921875
▁by 4.2109375
▁comparing 10.3359375
▁the 1.5244140625
▁effects 3.193359375
▁of 0.02545166015625
▁ph 5.6484375
arma 0.351806640625
ce 0.0159912109375
ut 0.00013244152069091797
ical 0.024871826171875
▁op 0.9990234375
io 3.14453125
ids 0.0938720703125
▁and 0.40966796875
▁MM 4.2265625
. 1.84765625
<0x0A> 0.417724609375
The 1.142578125
▁question 6.07421875
na 1.9541015625
ires 0.00013208389282226562
▁used 2.328125
▁different 8.9765625
▁variable 9.84375
▁measures 3.921875
▁to 1.71875
▁collect 3.962890625
▁information 1.896484375
. 1.4013671875
▁For 2.767578125
▁example 0.72900390625
, 0.004253387451171875
▁it 4.66015625
▁included 2.11328125
▁compreh 9.265625
ensive 0.061004638671875
▁so 6.4140625
cio 0.00435638427734375
- 0.2401123046875
dem 0.0975341796875
ographic 0.0849609375
▁data 0.96240234375
: 4.4765625
▁gender 1.810546875
, 0.060028076171875
▁age 0.244873046875
, 0.036651611328125
▁country 4.75
, 1.0595703125
▁type 4.375
▁of 0.0704345703125
▁residence 4.5078125
▁( 1.79296875
urban 0.5732421875
/ 1.181640625
r 0.12384033203125
ural 0.0007252693176269531
), 0.289794921875
▁years 5.765625
▁of 0.1864013671875
▁education 0.7060546875
, 0.19482421875
▁and 1.5595703125
▁employ 2.19921875
ment 0.0018291473388671875
▁status 0.66796875
. 0.193359375
▁Pat 4.890625
ients 0.1612548828125
▁were 1.0986328125
▁also 1.0732421875
▁asked 0.364501953125
▁about 1.0234375
▁their 0.8662109375
▁medical 2.07421875
▁history 0.49072265625
▁over 8.3359375
▁the 0.0738525390625
▁years 4.6640625
▁and 1.88671875
▁the 1.498046875
▁current 2.2421875
▁presence 5.90625
▁of 0.0736083984375
▁any 2.02734375
▁severe 3.85546875
▁dise 1.9384765625
ases 0.0001214742660522461
▁such 4.28515625
▁as 0.0022220611572265625
▁heart 2.650390625
▁failure 1.6953125
, 0.310546875
▁di 1.6826171875
ab 0.0010271072387695312
etes 0.0028972625732421875
, 0.0877685546875
▁ar 3.84765625
th 0.140380859375
rit 0.02947998046875
is 0.00487518310546875
, 0.0535888671875
▁and 1.47265625
▁so 2.279296875
▁on 0.162353515625
. 0.049591064453125
▁The 1.662109375
▁third 5.8984375
▁measure 4.50390625
▁of 2.55078125
▁the 1.3818359375
▁question 1.1083984375
naire 0.1512451171875
▁was 1.0810546875
▁indicated 10.984375
▁by 1.3447265625
▁information 7.6875
▁on 1.8994140625
▁any 5.13671875
▁twelve 14.015625
- 0.1470947265625
month 0.1490478515625
▁and 5.0234375
▁lifetime 0.60205078125
▁drug 3.65625
▁and 1.908203125
▁alco 0.1334228515625
hol 8.654594421386719e-05
▁consumption 4.83984375
. 0.48583984375
▁In 3.556640625
▁addition 1.103515625
, 0.25244140625
▁the 1.103515625
▁record 9.984375
▁included 1.5341796875
▁a 2.607421875
▁pain 3.74609375
▁measurement 4.8203125
▁scale 0.82958984375
▁from 4.14453125
▁ 0.47998046875
0 0.2998046875
▁to 0.24072265625
▁ 0.005702972412109375
1 0.057891845703125
0 0.023040771484375
▁to 3.7890625
▁evaluate 2.25
▁dis 6.015625
com 0.1181640625
fort 0.0009732246398925781
▁feelings 7.15234375
▁during 3.90625
▁the 0.29638671875
▁last 0.7919921875
▁month 1.8173828125
. 0.23876953125
<0x0A> 1.0927734375
Chr 6.6875
onic 0.0205078125
▁pain 0.26708984375
▁is 1.3486328125
▁still 6.015625
▁considered 3.19140625
▁to 1.7021484375
▁be 0.07403564453125
▁an 2.8125
▁extreme 5.84765625
▁issue 4.2578125
▁among 3.283203125
▁at 8.859375
▁least 0.1630859375
▁ 0.34228515625
8 3.7265625
% 1.197265625
▁of 0.06451416015625
▁the 0.708984375
▁residents 7.39453125
▁of 0.60009765625
▁progress 11.5546875
ive 0.1131591796875
▁countries 0.388916015625
. 0.904296875
▁The 1.994140625
▁introduction 7.38671875
▁of 0.01337432861328125
▁the 3.572265625
▁study 5.2109375
▁describes 5.3828125
▁the 0.7958984375
▁apparent 8.4375
▁link 4.2265625
▁between 0.1092529296875
▁pain 1.828125
▁and 0.444580078125
▁dem 8.0546875
oral 1.8359375
ization 0.0947265625
. 0.99365234375
▁Chron 4.5390625
ic 0.01062774658203125
▁pain 0.2357177734375
▁is 1.51953125
▁always 5.23828125
▁accompanied 1.5048828125
▁by 0.02886962890625
▁negative 3.775390625
▁emot 0.52001953125
ional 0.93603515625
▁experiences 3.48046875
▁and 2.033203125
▁blocks 11.1640625
▁a 2.927734375
▁person 0.859375
’ 0.436767578125
s 0.001407623291015625
▁ability 1.341796875
▁to 0.0247344970703125
▁receive 6.4765625
▁joy 3.333984375
▁and 1.142578125
▁satisfaction 2.330078125
▁from 0.64208984375
▁life 0.85107421875
. 0.261474609375
▁The 1.935546875
▁research 2.2109375
▁investig 6.0
ates 0.5302734375
▁the 0.51025390625
▁development 6.8671875
▁of 0.07708740234375
▁de 1.16796875
pression 0.394287109375
▁and 0.42041015625
▁anx 0.081787109375
iety 0.0006766319274902344
▁among 1.2041015625
▁patients 1.01171875
▁receiving 1.974609375
▁ph 2.77734375
arma 0.13818359375
ce 0.002353668212890625
ut 8.940696716308594e-06
ical 0.00354766845703125
▁op 0.64501953125
io 0.349365234375
ids 0.1776123046875
▁and 0.76318359375
▁medical 0.88623046875
▁mar 0.0693359375
iju 0.0005435943603515625
ana 2.9087066650390625e-05
▁( 3.1796875
MM 0.779296875
) 1.361328125
▁as 1.6259765625
▁severe 9.234375
▁pain 0.167236328125
kill 3.3125
ers 0.00019049644470214844
. 0.11529541015625
▁It 2.712890625
▁comp 4.02734375
ares 0.005474090576171875
▁the 0.53515625
▁effic 4.3671875
acy 0.00562286376953125
▁of 0.29150390625
▁pres 6.4296875
cri 2.28125
ptions 0.53076171875
▁and 1.228515625
▁exam 4.453125
ines 0.00354766845703125
▁the 0.66015625
▁possibility 4.05078125
▁of 0.0894775390625
▁post 9.0625
- 0.361328125
tre 1.44921875
at 0.0015268325805664062
ment 0.003292083740234375
▁de 1.7177734375
pression 0.17822265625
. 1.447265625
<0x0A> 0.471923828125
The 0.7099609375
▁study 1.8515625
▁conducted 4.77734375
▁a 1.2822265625
▁correlation 7.1171875
▁type 9.4140625
▁of 0.341796875
▁research 0.85986328125
▁with 2.8046875
▁variable 8.25
▁measures 0.62060546875
. 1.021484375
▁It 1.4013671875
▁evaluated 5.0234375
▁the 0.62744140625
▁inter 6.25
dep 2.6484375
end 0.00019884109497070312
ence 0.006195068359375
▁of 0.6630859375
▁various 3.87109375
▁factors 0.89697265625
▁that 2.802734375
▁affected 4.05078125
▁the 0.54833984375
▁physical 6.109375
▁and 0.222900390625
▁emot 0.6865234375
ional 0.0001589059829711914
▁condition 1.5224609375
▁of 0.05548095703125
▁patients 0.58740234375
▁experien 3.392578125
cing 7.665157318115234e-05
▁chron 0.51171875
ic 0.0003001689910888672
▁pain 0.03729248046875
. 0.11383056640625
▁For 3.640625
▁example 0.394775390625
, 0.0008387565612792969
▁the 1.0693359375
▁survey 4.0390625
▁showed 3.955078125
▁that 0.75048828125
▁the 1.9609375
▁ratio 7.03515625
▁of 0.150146484375
▁female 3.1328125
▁patients 1.173828125
▁was 1.119140625
▁remark 7.9765625
ably 0.00014090538024902344
▁higher 0.1492919921875
▁in 3.572265625
▁the 1.888671875
▁op 3.09765625
i 2.080078125
ates 0.01052093505859375
▁group 0.147705078125
▁compared 2.439453125
▁to 0.033599853515625
▁the 0.923828125
▁MM 0.1859130859375
▁group 1.005859375
. 0.288330078125
▁In 3.09765625
▁turn 4.8125
, 0.0008115768432617188
▁people 4.38671875
▁on 4.6484375
▁op 2.228515625
i 0.393798828125
ates 0.0021514892578125
▁were 1.078125
▁more 1.337890625
▁likely 0.2003173828125
▁to 0.0183868408203125
▁report 3.35546875
▁major 6.14453125
▁de 0.71875
press 0.77587890625
ive 0.001434326171875
▁dis 1.0458984375
orders 1.5029296875
. 1.8046875
<0x0A> 2.291015625
Part 6.3359375
icip 0.422119140625
ants 0.10626220703125
▁were 1.3017578125
▁rec 3.62109375
ru 0.0007557868957519531
ited 4.875659942626953e-05
▁for 4.44921875
▁six 5.79296875
▁months 0.38037109375
▁at 3.4765625
▁two 2.38671875
▁major 3.080078125
▁pain 2.30859375
▁relief 4.29296875
▁cent 0.8037109375
ers 0.01097869873046875
▁in 0.65087890625
▁Israel 3.640625
. 0.3486328125
▁All 3.49609375
▁patients 1.2490234375
▁experienced 4.16796875
▁chron 1.0654296875
ic 0.00014030933380126953
▁pain 0.1607666015625
▁for 1.509765625
▁at 0.58251953125
▁least 0.00215911865234375
▁ 1.603515625
3 1.7626953125
▁months 0.285888671875
. 1.3154296875
▁The 1.37890625
▁study 2.392578125
▁included 1.337890625
▁ 0.47265625
8 3.12109375
9 2.494140625
0 2.91796875
▁participants 2.12890625
, 1.5263671875
▁of 2.7734375
▁which 0.38427734375
▁ 0.09539794921875
4 1.169921875
7 2.48046875
4 2.59765625
▁( 2.73046875
5 0.0892333984375
9 4.96484375
%) 0.55078125
▁were 0.90185546875
▁treated 3.484375
▁sole 7.41796875
ly 0.00019800662994384766
▁with 0.3388671875
▁op 0.63232421875
io 1.1123046875
ids 0.10223388671875
, 0.62646484375
▁ 1.4228515625
3 1.1904296875
2 2.265625
9 2.408203125
▁( 0.05615234375
4 2.45703125
1 0.95654296875
%) 0.040863037109375
▁were 1.669921875
▁treated 0.78955078125
▁with 0.393310546875
▁MM 0.6064453125
, 0.34912109375
▁and 0.09912109375
▁ 0.254150390625
7 1.916015625
7 2.3671875
▁( 0.1212158203125
8 1.6162109375
. 0.98779296875
6 2.205078125
%) 0.046142578125
▁acquired 10.3046875
▁both 0.5380859375
▁( 4.93359375
Fe 0.9892578125
ing 0.0027256011962890625
old 0.000759124755859375
▁et 0.02423095703125
▁al 0.0018682479858398438
., 0.0123291015625
▁ 0.0014677047729492188
2 0.0002002716064453125
0 8.082389831542969e-05
1 0.0020046234130859375
7 0.01641845703125
). 0.0102386474609375
▁The 1.14453125
▁remaining 7.00390625
▁ten 6.51953125
▁participants 1.3642578125
▁who 4.92578125
▁did 2.0703125
▁not 0.005321502685546875
▁receive 2.265625
▁ph 4.44921875
arma 0.2113037109375
ce 0.0014705657958984375
ut 4.291534423828125e-06
ical 0.0025310516357421875
▁op 2.2265625
io 0.1644287109375
ids 0.0214691162109375
▁and 2.271484375
▁medical 2.099609375
▁mar 0.044769287109375
iju 0.0003421306610107422
ana 8.046627044677734e-05
▁were 0.46337890625
▁with 6.734375
dra 0.045257568359375
wn 1.2874603271484375e-05
▁from 0.2457275390625
▁the 0.205810546875
▁analysis 1.708984375
▁in 5.42578125
▁the 1.0771484375
▁research 4.91796875
. 0.89501953125
▁Therefore 5.01171875
, 0.008148193359375
▁it 3.44140625
▁is 1.2939453125
▁not 2.611328125
▁possible 1.1904296875
▁to 0.0034198760986328125
▁compreh 6.25
ens 0.10406494140625
ively 0.019073486328125
▁compare 1.4599609375
▁patients 4.6328125
▁taking 3.880859375
▁medic 4.2421875
ations 0.58935546875
▁with 1.5244140625
▁those 1.0546875
▁who 0.6796875
▁do 1.4697265625
▁not 0.0037097930908203125
. 0.607421875
<0x0A> 0.52685546875
The 0.70654296875
▁study 2.017578125
▁was 2.521484375
▁conducted 1.01953125
▁in 1.080078125
▁the 2.341796875
▁form 2.654296875
▁of 0.0015497207641601562
▁collection 9.734375
▁and 0.75244140625
▁analysis 0.409423828125
▁of 0.034515380859375
▁statistical 3.15234375
▁data 0.1827392578125
. 0.58251953125
▁Part 4.421875
icip 0.1064453125
ants 0.0273895263671875
▁were 0.99755859375
▁rec 3.38671875
ru 0.00039887428283691406
ited 2.0742416381835938e-05
▁for 2.111328125
▁six 0.43505859375
▁months 0.004390716552734375
▁at 0.454833984375
▁two 0.053497314453125
▁major 0.1234130859375
▁pain 0.045318603515625
▁relief 0.027435302734375
▁cent 0.01448822021484375
ers 0.0005011558532714844
▁in 0.038543701171875
▁Israel 0.005878448486328125
. 0.1207275390625
▁The 1.6015625
▁research 1.73046875
ers 1.0302734375
▁used 1.9658203125
▁The 8.7734375
▁De 3.431640625
pression 0.039947509765625
▁Module 6.0
▁of 0.57568359375
▁the 0.175048828125
▁Pat 2.59375
ient 0.00470733642578125
▁Health 0.0215911865234375
▁Question 0.010650634765625
naire 0.020599365234375
▁and 3.25
▁the 0.7451171875
▁General 1.0029296875
ized 0.54296875
▁An 0.003631591796875
x 0.00010144710540771484
iety 0.0003333091735839844
▁Dis 0.1826171875
order 0.02783203125
▁Sc 1.794921875
ale 0.0016651153564453125
▁to 0.80126953125
▁interview 8.3984375
▁participants 2.57421875
, 4.65625
▁evaluate 4.01171875
▁their 0.69970703125
▁answers 4.40234375
, 0.2349853515625
▁and 0.0279693603515625
▁conduct 4.23828125
▁the 1.974609375
▁study 3.162109375
. 0.2423095703125
▁To 5.26171875
▁specifically 9.03125
▁evaluate 2.708984375
▁and 5.05078125
▁compare 0.51708984375
▁the 0.5263671875
▁prob 10.5078125
abilities 0.0238494873046875
▁of 0.06475830078125
▁de 0.61376953125
pression 0.135009765625
▁or 4.91796875
▁anx 0.045074462890625
iety 0.000598907470703125
▁among 1.228515625
▁the 2.611328125
▁diverse 9.1484375
▁groups 0.736328125
, 0.7998046875
▁the 0.403564453125
▁study 2.6171875
▁used 0.966796875
▁multiple 4.7265625
▁log 0.8095703125
istic 0.018402099609375
▁regression 0.256591796875
▁analysis 1.20703125
▁and 2.828125
▁chose 8.921875
▁medical 6.26953125
▁mar 0.10540771484375
iju 0.000919342041015625
ana 3.552436828613281e-05
▁as 0.48974609375
▁the 0.849609375
▁control 2.232421875
▁group 0.90185546875
. 0.387451171875
<0x0A> 0.391357421875
This 3.583984375
▁type 3.59765625
▁of 0.0019273757934570312
▁study 2.12890625
▁is 1.390625
▁the 3.98046875
▁most 0.68212890625
▁reve 8.140625
aling 0.0004527568817138672
▁and 1.27734375
▁inclus 7.0234375
ive 0.0010843276977539062
, 2.79296875
▁as 0.84619140625
▁it 0.2259521484375
▁contains 4.6875
▁direct 5.63671875
▁responses 4.3515625
▁from 0.505859375
▁a 3.748046875
▁large 0.7763671875
▁number 0.486572265625
▁of 0.001941680908203125
▁participants 1.1484375
. 0.51416015625
▁All 4.88671875
▁tools 9.1328125
▁in 5.76953125
▁the 0.63916015625
▁form 3.81640625
▁of 0.01531219482421875
▁question 0.42138671875
na 0.0089263916015625
ires 1.049041748046875e-05
▁and 1.041015625
▁scales 2.892578125
▁have 3.28125
▁already 4.328125
▁been 0.3388671875
▁used 2.640625
▁and 1.6640625
▁proved 2.435546875
▁their 1.365234375
▁effic 2.984375
acy 0.002490997314453125
▁for 3.3203125
▁collect 2.896484375
ing 0.004146575927734375
▁analyt 7.0078125
ical 0.07098388671875
▁data 0.283935546875
. 0.3056640625
▁It 2.716796875
▁helps 4.26953125
▁to 0.6279296875
▁system 5.90625
at 0.59912109375
ize 0.0011844635009765625
▁and 1.23828125
▁class 4.671875
ify 0.0010957717895507812
▁distinct 8.1796875
▁kinds 6.80859375
▁of 0.015106201171875
▁information 1.3798828125
▁for 3.818359375
▁subsequent 4.6015625
▁un 8.4375
comp 4.47265625
licated 0.0257720947265625
▁services 13.0390625
. 0.56494140625
▁Thus 5.0078125
, 0.0035495758056640625
▁research 3.99609375
ers 0.2037353515625
▁can 1.3486328125
▁compare 2.46484375
▁the 1.263671875
▁effects 2.775390625
▁of 0.0625
▁medic 3.103515625
ations 0.332275390625
▁on 1.40234375
▁patients 1.671875
▁of 4.390625
▁diverse 3.515625
▁age 2.16796875
▁groups 2.91015625
, 0.416259765625
▁background 4.0703125
s 0.1768798828125
, 0.0104522705078125
▁physical 5.61328125
▁conditions 1.3955078125
, 0.02825927734375
▁emot 6.15625
ional 0.021728515625
▁states 0.97412109375
, 0.035858154296875
▁and 0.199951171875
▁so 1.396484375
▁on 0.09515380859375
. 0.060028076171875
<0x0A> 0.626953125
Am 6.52734375
ong 0.0242462158203125
▁all 2.146484375
▁participants 2.240234375
▁in 3.12890625
▁the 0.1669921875
▁study 0.497314453125
, 0.060272216796875
▁ 0.93798828125
4 1.7001953125
2 2.759765625
. 1.26953125
2 2.263671875
% 0.051025390625
▁suffered 4.09375
▁from 0.0447998046875
▁de 1.4775390625
pression 0.252685546875
, 0.96337890625
▁and 1.1552734375
▁ 0.11016845703125
3 1.3388671875
7 2.3359375
% 2.595703125
▁experienced 2.017578125
▁excess 6.5859375
ive 0.02496337890625
▁anx 0.202880859375
iety 0.0017910003662109375
. 0.40380859375
▁The 1.484375
▁pl 10.7421875
ur 0.54296875
ality 0.0006003379821777344
▁of 0.11090087890625
▁de 2.609375
press 1.3681640625
ive 0.04095458984375
▁dis 2.541015625
orders 0.06915283203125
▁among 2.8515625
▁patients 1.01171875
▁in 3.158203125
▁the 0.2822265625
▁op 0.54150390625
i 0.5224609375
ates 0.0012531280517578125
, 8.890625
▁medical 2.99609375
▁mar 0.0203399658203125
iju 0.0007982254028320312
ana 1.2278556823730469e-05
, 0.1474609375
▁and 0.08709716796875
▁mixed 1.431640625
▁OP 11.1484375
MM 4.05859375
▁groups 0.53564453125
▁number 9.6796875
ed 0.022979736328125
▁ 0.1607666015625
5 1.5146484375
7 2.6015625
. 0.5673828125
1 2.515625
%, 0.18505859375
▁ 0.0032787322998046875
2 2.654296875
2 2.615234375
. 0.107177734375
3 2.2578125
%, 0.044097900390625
▁and 0.0443115234375
▁ 0.0017108917236328125
5 2.09765625
1 2.0703125
. 0.155029296875
4 1.9541015625
%, 0.1519775390625
▁respectively 0.0231475830078125
. 0.2392578125
▁The 1.2392578125
▁pl 3.298828125
ur 0.00830078125
ality 4.112720489501953e-05
▁of 0.024658203125
▁anx 0.435546875
iety 0.017181396484375
▁contained 10.890625
▁ 0.25390625
4 1.1337890625
8 2.376953125
. 0.1600341796875
4 2.1875
% 1.8076171875
▁among 2.36328125
▁OP 4.82421875
▁patients 5.77734375
, 0.2432861328125
▁ 0.0689697265625
2 0.9248046875
1 2.41015625
. 0.11053466796875
5 2.103515625
% 0.0237884521484375
▁among 0.445556640625
▁MM 0.11480712890625
▁patients 0.334228515625
, 0.01410675048828125
▁and 0.013702392578125
▁ 0.0224609375
3 1.47265625
8 1.8935546875
. 0.12005615234375
7 2.208984375
% 0.01012420654296875
▁among 0.1806640625
▁OP 1.78125
MM 0.1253662109375
▁participants 3.69140625
. 0.252685546875
▁Pat 5.08984375
ients 0.0157928466796875
▁who 1.91796875
▁took 2.3984375
▁strong 9.7734375
▁op 0.79443359375
i 0.85986328125
ates 0.0025806427001953125
▁were 1.328125
▁t 10.3125
ended 1.072265625
▁to 0.006988525390625
▁place 10.1015625
▁their 2.24609375
▁pain 1.9462890625
▁on 1.8681640625
▁a 0.5849609375
▁scale 1.728515625
▁of 0.362060546875
▁ 0.09686279296875
9 2.765625
▁to 2.2109375
▁ 0.00994110107421875
1 0.005451202392578125
0 0.010162353515625
▁( 2.59375
Fe 1.103515625
ing 0.002735137939453125
old 0.0004897117614746094
▁et 0.0050048828125
▁al 0.0006899833679199219
., 0.00582122802734375
▁ 0.0007791519165039062
2 0.00014829635620117188
0 0.00014913082122802734
1 0.0006542205810546875
7 0.0027828216552734375
). 0.00997161865234375
▁They 3.74609375
▁were 1.623046875
▁also 0.93701171875
▁an 9.515625
gu 4.87890625
ished 0.0770263671875
▁em 6.12109375
otion 0.0007243156433105469
ally 0.0005602836608886719
▁and 1.076171875
▁react 7.5
ed 0.0244140625
▁rad 9.078125
ically 0.0013408660888671875
▁neg 5.10546875
atively 0.001270294189453125
▁to 0.189697265625
▁almost 5.59375
▁all 1.552734375
▁survey 4.140625
▁questions 0.2451171875
. 0.28662109375
▁Pat 3.560546875
ients 0.004039764404296875
▁who 1.1923828125
▁took 1.677734375
▁only 4.3203125
▁MM 0.5
▁or 2.625
▁mixed 2.271484375
▁medic 1.3896484375
ations 0.1893310546875
▁course 13.703125
▁had 2.435546875
▁a 1.4599609375
▁significantly 2.7578125
▁more 3.240234375
▁stable 2.740234375
▁emot 0.9111328125
ional 0.0010786056518554688
▁state 0.50830078125
▁and 1.2021484375
▁cop 6.8125
ed 0.0198974609375
▁with 0.306640625
▁pain 0.845703125
▁more 1.8388671875
▁manage 6.17578125
able 1.5517578125
. 0.28564453125
